Antifungal 4-substituted 5,6-dihydro-4H-pyrrolo [1,2-a][1,4]benzodiazepines
    1.
    发明授权
    Antifungal 4-substituted 5,6-dihydro-4H-pyrrolo [1,2-a][1,4]benzodiazepines 有权
    抗真菌4-取代的5,6-二氢-4H-吡咯并[1,2-a] [1,4]苯并二氮杂卓

    公开(公告)号:US07820650B2

    公开(公告)日:2010-10-26

    申请号:US11680700

    申请日:2007-03-01

    摘要: The present invention concerns compounds for use as a medicine having the formula the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.

    摘要翻译: 本发明涉及用作具有N-氧化物形式的药物的化合物,其盐,季胺和立体化学异构形式,其中R 1表示氢,C 1-6烷基,C 1-4烷硫基,C 1-4烷氧基或卤素 ; R 2表示氢或C 1-6烷基; R 3表示被卤素,氰基,C 1-4烷氧基,C 1-4烷硫基,C 1-6烷基,卤代C 1-6烷基取代的苯基; 2-噻吩基; 或3-噻吩基,R 4表示氢; 或R2和R4形成额外的键,其对皮肤癣菌有活性,并且它们的制备; 它还涉及包含它们的组合物以及它们作为药物的用途。

    Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines
    2.
    发明授权
    Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines 有权
    抗真菌剂4-取代的5,6-二氢-4H-吡咯并[1,2-a] [1,4]苯并二氮杂卓

    公开(公告)号:US07202240B2

    公开(公告)日:2007-04-10

    申请号:US10399596

    申请日:2001-10-17

    摘要: The present invention concerns compounds for use as a medicine having the formula (I), the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6 alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.

    摘要翻译: 本发明涉及用作具有式(I)的药物,N-氧化物形式,其盐,季胺及其立体化学异构形式的化合物,其中R 1表示氢, C 1-4烷基,C 1-4烷基硫基,C 1-4烷基氧基或卤素; R 2表示氢或C 1-6烷基; R 3表示被卤素,氰基,C 1-4烷氧基,C 1-4烷基硫基,C 1-6烷基取代的苯基 烷基,卤代C 1-6烷基; 2-噻吩基; 或3-噻吩基,R 4表示氢; 或R 2和R 4形成对皮肤癣菌有活性的额外的结合,及其制备; 它还涉及包含它们的组合物以及它们作为药物的用途。

    ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES
    3.
    发明申请
    ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES 有权
    反式4取代的5,6-二氢-4H-吡咯并[1,2-a] [1,4]苯并咪唑

    公开(公告)号:US20070232593A1

    公开(公告)日:2007-10-04

    申请号:US11680700

    申请日:2007-03-01

    IPC分类号: A61K31/55 C07D487/12

    摘要: The present invention concerns compounds for use as a medicine having the formula the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R1 represents hydrogen, C1-6alkyl, C1-4alkylthio, C1-4alkyloxy, or halo; R2 represents hydrogen or C1-6alkyl; R3 represents phenyl substituted with halo, cyano, C1-4alkyloxy, C1-4alkylthio, C1-6alkyl, haloC1-6alkyl; 2-thienyl; or 3-thienyl, R4 represents hydrogen; or R2 and R4 form an extra bond, which are active against dermatophytes, and their preparation; it further relates to compositions comprising them, as well as their use as a medicine.

    摘要翻译: 本发明涉及用作具有N-氧化物形式的药物的化合物,其盐,季胺和立体化学异构形式,其中R 1表示氢,C 1〜 C 1 -C 6烷基,C 1-4烷基硫基,C 1-4烷基氧基或卤素; R 2表示氢或C 1-6烷基; R 3表示被卤素,氰基,C 1-4烷氧基,C 1-4烷基硫基,C 1-6烷基取代的苯基 烷基,卤代C 1-6烷基; 2-噻吩基; 或3-噻吩基,R 4表示氢; 或R 2和R 4形成对皮肤癣菌有活性的额外的结合,及其制备; 它还涉及包含它们的组合物以及它们作为药物的用途。

    PIPERIDINE/PIPERAZINE DERIVATIVES
    8.
    发明申请
    PIPERIDINE/PIPERAZINE DERIVATIVES 有权
    哌啶/哌嗪衍生物

    公开(公告)号:US20100216809A1

    公开(公告)日:2010-08-26

    申请号:US12663009

    申请日:2008-06-05

    摘要: The invention further relates to a DGAT inhibitor of formula (I), including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —NRx—C(═O)—; —Z—C(═O)—; —Z—NRx—C(═O)—; —S(═O)p-; C(═S)—; —NRx—C(═S)—; —Z—C(═S)—; —Z—NRx—C(═S)—; —O—C(═O)—; —C(═O)—C(═O)—; R1 represents a 5-membered monocyclic heterocycle containing at least 2 heteroatoms; a 6-membered aromatic monocyclic heterocycle; or a 5-membered heterocycle containing at least 2 heteroatoms fused with phenyl, cyclohexyl or a 5-or 6-membered heterocycle; wherein each of said heterocycles may optionally be substituted; R2 represents R3; R3 represents C3-6cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzodioxinyl, 1,3-benzodioxlyl, 2,3-dihydrobenzofuranyl or a 6-membered aromatic heterocycle containing 1 or 2 N atoms, wherein said C3-6cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzo-dioxinyl, 1,3-benzodioxolyl, 2,3-dihydrobenzofuranyl or 6-membered aromatic heterocycle may optionally be substituted; a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds.

    摘要翻译: 本发明还涉及式(I)的DGAT抑制剂,其包括其任何立体化学异构形式,其中A表示CH或N; 在A代表碳原子的情况下,虚线代表任意键; X表示-NR x -C(= O) - ; -Z-C(= O) - ; -Z-NRx-C(= O) - ; -S(= O)p-; C(═S) - ; -NR x -C(= S) - ; -Z-C(= S) - ; -Z-NRx-C(= S) - ; -O-C(= O) - ; -C(= O)-C(= O) - ; R1表示含有至少2个杂原子的5元单环杂环; 6元芳族单环杂环; 或含有至少2个与苯基,环己基或5或6元杂环稠合的杂原子的5元杂环; 其中每个所述杂环可任选被取代; R2表示R3; R 3表示C 3-6环烷基,苯基,萘基,2,3-二氢-1,4-苯并二氧杂环己烯基,1,3-苯并二恶唑基,2,3-二氢苯并呋喃基或含1或2个N原子的6元芳族杂环,其中所述C3 6-环烷基,苯基,萘基,2,3-二氢-1,4-苯并二恶基,1,3-苯并二恶唑基,2,3-二氢苯并呋喃基或6-元芳香杂环可以任选被取代; 其N-氧化物,其药学上可接受的盐或其溶剂合物。 本发明还涉及制备这些化合物的方法,包含所述化合物的药物组合物以及用作所述化合物的药物。